Skip to main content
Erschienen in: Clinical Rheumatology 3/2007

01.03.2007 | Original Article

Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil

verfasst von: Eutília A. M. Freire, Inês O. Maia, Jamile C. A. Nepomuceno, Rozana M. Ciconelli

Erschienen in: Clinical Rheumatology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects mainly young women. During the disease course, many organs and systems can suffer non-reversible damage that decreases both the patient’s life span and also their quality of life. To determine the chronic damage and its correlation with quality of life, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index was used in 63 patients who met the ACR criteria for SLE. Quality of life (QOL) was measured through the Medical Outcomes Survey short form 36 (SF-36), sociodemographic data were assessed using specific questionnaires, and disease activity was measured by the systemic lupus erythematosus disease activity index. Overall, 32% of the patients presented damage. Neuropsychiatric (25%) and vascular (20%) involvement were the most frequently related. Organic damages were associated with disease duration (p < 0.03). General health status and social aspects of quality of life were also associated with disease duration (p < 0.05 and p < 0.038, respectively). Socioeconomic status and disease activity were not associated with organic damages and quality of life. This study concluded that disease activity, cumulative damage, and quality of life had some influence in the overall view of lupus but those parameters are distinct domains of health status in SLE. Our analysis identified that disease duration had an important association with damage index and general health status.
Literatur
1.
Zurück zum Zitat Hochberg MC, Dorsch CA, Feinglass EJ, Stevens MB (1981) Survivorship in systemic lupus erythematosus: effect of antibody to extractable nuclear antigen. Arthritis Rheum 24:54–59PubMed Hochberg MC, Dorsch CA, Feinglass EJ, Stevens MB (1981) Survivorship in systemic lupus erythematosus: effect of antibody to extractable nuclear antigen. Arthritis Rheum 24:54–59PubMed
2.
Zurück zum Zitat Hochberg MC (1984) Systemic lupus erythematosus VIII. Prognosis. Md State Med J 33:114–116PubMed Hochberg MC (1984) Systemic lupus erythematosus VIII. Prognosis. Md State Med J 33:114–116PubMed
3.
Zurück zum Zitat Hochberg MC (1985) Collagen–vascular disease and disability. In: Hadler NM, Gillings DB (eds) Arthritis and society. Butterworth, London Hochberg MC (1985) Collagen–vascular disease and disability. In: Hadler NM, Gillings DB (eds) Arthritis and society. Butterworth, London
4.
Zurück zum Zitat Ginzler E, Berg A (1987) Mortality in systemic lupus erythematosus. J Rheumatol 14:218–222 Ginzler E, Berg A (1987) Mortality in systemic lupus erythematosus. J Rheumatol 14:218–222
5.
Zurück zum Zitat Swaak AJ, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L, Smeenk RJ (1989) Systemic lupus erythematosus. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447–454PubMedCrossRef Swaak AJ, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L, Smeenk RJ (1989) Systemic lupus erythematosus. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447–454PubMedCrossRef
6.
Zurück zum Zitat Gladman DD (1992) Prognosis of SLE and factors that affect it. Curr Opin Rheumatol 3:789–796CrossRef Gladman DD (1992) Prognosis of SLE and factors that affect it. Curr Opin Rheumatol 3:789–796CrossRef
7.
Zurück zum Zitat Gladman D, Urowitz M, Fortin P, Isenberg D, Goldsmith C, Gordon C, Petri M (1996) Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 23:1953–1955PubMed Gladman D, Urowitz M, Fortin P, Isenberg D, Goldsmith C, Gordon C, Petri M (1996) Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 23:1953–1955PubMed
8.
Zurück zum Zitat Gladman D, Ginzler E, Goldsmith C, Fortin P, Leang M, Urowitz M, Bacon P, Bombardiere S, Hanly J, Hanly J, Hay E, Isenberg D, Imes J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zomia A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369PubMed Gladman D, Ginzler E, Goldsmith C, Fortin P, Leang M, Urowitz M, Bacon P, Bombardiere S, Hanly J, Hanly J, Hay E, Isenberg D, Imes J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zomia A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369PubMed
9.
Zurück zum Zitat Fallowfield L (1992) An overview of quality of life measurements. In: Trimble MR, Dodson WE (eds) Epilepsy and quality of Life. Raven, New York Fallowfield L (1992) An overview of quality of life measurements. In: Trimble MR, Dodson WE (eds) Epilepsy and quality of Life. Raven, New York
10.
Zurück zum Zitat Testa MA, Simonson DC (1996) Assessment of quality of life outcomes. N Engl J Med 334:835–840PubMedCrossRef Testa MA, Simonson DC (1996) Assessment of quality of life outcomes. N Engl J Med 334:835–840PubMedCrossRef
11.
Zurück zum Zitat Gladman DD, Urowitz M, Ong A, Gough J, Mackinnon A (1996) A comparison of 5 health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 5:190–195PubMed Gladman DD, Urowitz M, Ong A, Gough J, Mackinnon A (1996) A comparison of 5 health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 5:190–195PubMed
12.
Zurück zum Zitat Stewart AL, Hays RD, Ware JE (1988) The MOS short-form general health survey: reliability and validity in a patient population. Med Care 26:724–735PubMedCrossRef Stewart AL, Hays RD, Ware JE (1988) The MOS short-form general health survey: reliability and validity in a patient population. Med Care 26:724–735PubMedCrossRef
13.
Zurück zum Zitat Fries JF, Spetz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145PubMed Fries JF, Spetz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145PubMed
14.
Zurück zum Zitat Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR (1999) Brazilian–Portuguese version of the SF-36. Reliable and valid quality of life outcome measure. Rev Bras Reumatol 39:143–150 Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR (1999) Brazilian–Portuguese version of the SF-36. Reliable and valid quality of life outcome measure. Rev Bras Reumatol 39:143–150
15.
Zurück zum Zitat Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, Isenberg DA (1997) Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus and a comparison with the MOS SF-20. J Rheumatol 24:1608–1614PubMed Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, Isenberg DA (1997) Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus and a comparison with the MOS SF-20. J Rheumatol 24:1608–1614PubMed
16.
Zurück zum Zitat Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, Danoff D (1998) Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 7:101–107PubMedCrossRef Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, Danoff D (1998) Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 7:101–107PubMedCrossRef
17.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShanie DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythomatosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShanie DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythomatosus. Arthritis Rheum 25:1271–1277PubMed
18.
Zurück zum Zitat Bombardier C, Gladman DD, Urowitz M, Caron D, Chang CH (1992) The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630–640PubMed Bombardier C, Gladman DD, Urowitz M, Caron D, Chang CH (1992) The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630–640PubMed
19.
Zurück zum Zitat Gladman DD (1994) Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 6:487–492PubMedCrossRef Gladman DD (1994) Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 6:487–492PubMedCrossRef
20.
Zurück zum Zitat Rivest C, Lew RA, Welseng PM, Sangha O, Wright EA, Roberts WN, Liang MH, Karlson EW (2000) Association between clinical factors, socio-economic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 27:680–684PubMed Rivest C, Lew RA, Welseng PM, Sangha O, Wright EA, Roberts WN, Liang MH, Karlson EW (2000) Association between clinical factors, socio-economic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 27:680–684PubMed
21.
Zurück zum Zitat Gladman DD, Urowitz M, Ong A, Gough J, MacKinnon A (1996) Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 14:305–308PubMed Gladman DD, Urowitz M, Ong A, Gough J, MacKinnon A (1996) Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 14:305–308PubMed
22.
Zurück zum Zitat Ferraz LB (2001) Avaliação da qualidade de vida em pacientes com Lupus Eritematoso com manifestações cutâneas. UNIFESP, (Tese) São Paulo Ferraz LB (2001) Avaliação da qualidade de vida em pacientes com Lupus Eritematoso com manifestações cutâneas. UNIFESP, (Tese) São Paulo
23.
Zurück zum Zitat Meinão I (2001) Utilização de recursos e custos em pacientes com Lupus Eritematoso Sistêmico. UNIFESP, (Tese) São Paulo Meinão I (2001) Utilização de recursos e custos em pacientes com Lupus Eritematoso Sistêmico. UNIFESP, (Tese) São Paulo
24.
Zurück zum Zitat D’Amorim AB (2001) Avaliação das formas auto-administrativas dos questionários MHAQ e SF-12 em pacientes com doenças reumatológicas. UNIFESP, (Tese) São Paulo D’Amorim AB (2001) Avaliação das formas auto-administrativas dos questionários MHAQ e SF-12 em pacientes com doenças reumatológicas. UNIFESP, (Tese) São Paulo
Metadaten
Titel
Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil
verfasst von
Eutília A. M. Freire
Inês O. Maia
Jamile C. A. Nepomuceno
Rozana M. Ciconelli
Publikationsdatum
01.03.2007
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 3/2007
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0517-6

Weitere Artikel der Ausgabe 3/2007

Clinical Rheumatology 3/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.